ConductScience.org, home

Trial · NCT07891858

Warm-Up Music Tempo and Time-of-Day Effects on Anaerobic Performance in Young Female Volleyball Players

NCT07891858, Not applicable, Completed, Inonu University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Warm-Up Music Tempo and Time-of-Day Effects on Anaerobic Performance in Young Female Volleyball Players. Trials, record NCT07891858. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07891858

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Warm-Up Music Tempo and Time-of-Day Effects on Anaerobic Performance in Young Female Volleyball Players
NCT number
NCT07891858
Status
Completed
Phases
Not applicable
Enrollment
13 participants, actual
Lead sponsor
Inonu University
Conditions
Anaerobic Performance, Athletic Performance, Warm-Up Music Tempo, Time-of-Day Effects
Interventions
No Music Warm-Up, Low-Tempo Music Warm-Up, Moderate-Tempo Music Warm-Up, Fast-Tempo Music Warm-Up
First posted
2026-10-23
Last updated
2026-10-23

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCountermovement Jump (CMJ) HeightImmediately after the standardized 10-minute warm-up in each of the 8 study sessions, through study completion (up to 11 weeks)
Countermovement jump height measured in centimetres after each warm-up condition and testing time; higher values indicate better jump performance. The jump-measurement device model, number of attempts, attempt-selection rule and inter-trial rest were not documented in the source records.
SecondaryJump-Derived Peak PowerImmediately after the standardized 10-minute warm-up in each of the 8 study sessions, through study completion (up to 11 weeks)Peak power expressed in watts and estimated from vertical jump height and body mass using the Sayers equation.
SecondaryRelative Peak PowerImmediately after the standardized 10-minute warm-up in each of the 8 study sessions, through study completion (up to 11 weeks)Relative peak power expressed as watts per kilogram and calculated by dividing jump-derived peak power by body mass.
SecondarySingle-Hand Handgrip StrengthImmediately after the warm-up and jump testing in each of the 8 study sessions, through study completion (up to 11 weeks)
Single-hand handgrip strength recorded with a hand dynamometer and reported in kilograms; higher values indicate greater grip strength. The dynamometer model, test hand, posture and number of attempts were not documented in the source records, and the recorded unit has not been confirmed against a device output.
SecondaryRating of Perceived ExertionImmediately after performance testing in each of the 8 study sessions, through study completion (up to 11 weeks)
Perceived exertion assessed with the Borg Rating of Perceived Exertion Scale (6 to 20 version). Scores range from a minimum of 6 (no exertion at all) to a maximum of 20 (maximal exertion); higher scores indicate greater perceived exertion.
OtherChronotype ScoreBaseline (before the first study session)
Chronotype assessed with the Horne-Ostberg Morningness-Eveningness Questionnaire. Total scores range from a minimum of 16 to a maximum of 86; higher scores indicate greater morningness and lower scores greater eveningness. The score describes a chronotype characteristic and is not a better or worse outcome.
OtherSubjective WellnessBaseline (before the first study session)
Subjective wellness assessed with the Hooper Questionnaire (Hooper index), comprising four items: sleep quality, fatigue, muscle soreness and stress. Each item is rated from 1 (very very good or very very low) to 7 (very very bad or very very high), giving a total index ranging from a minimum of 4 to a maximum of 28; higher scores indicate worse subjective wellness.
OtherSleep QualityBaseline (before the first study session)Sleep quality assessed with the Pittsburgh Sleep Quality Index. The global score ranges from a minimum of 0 to a maximum of 21; higher scores indicate worse sleep quality.
OtherMood StateBaseline (before the first study session)
Mood assessed with the Profile of Mood States (58-item version), comprising the tension, depression, anger, vigour, fatigue and confusion subscales. Each item is rated from a minimum of 0 (not at all) to a maximum of 4 (extremely). Total mood disturbance is calculated as the sum of the five negative subscales minus the vigour subscale; higher subscale and total mood disturbance scores indicate worse mood, except for vigour, where higher scores indicate better mood.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
31804098BACKGROUNDPubMed
32528038BACKGROUNDPubMed
33917781BACKGROUNDPubMed
37104494BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07891858

GET https://conductscience.org/api/trials/v1/NCT07891858/registered